ライフサイエンスコーパス: gastrointestinal disease

1 loped respiratory disease, and one developed gastrointestinal disease).

2 and return to active growth, they can cause gastrointestinal disease.

3 for multiple baseline risk factors for upper gastrointestinal disease.

4 erved that feces often smell abnormal during gastrointestinal disease.

5 he feces of healthy donors and patients with gastrointestinal disease.

6 imicry used to promote EPEC pathogenesis and gastrointestinal disease.

7 lammatory models of cardiac, neurologic, and gastrointestinal disease.

8 ne of the most frequent causes of nosocomial gastrointestinal disease.

9 oxibs among their patients with a history of gastrointestinal disease.

10 ccur in the intestines during CPE-associated gastrointestinal disease.

11 an important step in its ability to initiate gastrointestinal disease.

12 by contribute to the diarrhea of CPE-induced gastrointestinal disease.

13 e, high intakes of supplemental iron, or any gastrointestinal disease.

14 otoxic shock, with the development of severe gastrointestinal disease.

15 onse associated with cytomegalovirus-induced gastrointestinal disease.

16 use is a major contributor to the burden of gastrointestinal disease.

17 ram-negative bacterium, is a common cause of gastrointestinal disease.

18 spiral bacterium, is a common cause of human gastrointestinal disease.

19 ms in the generation of visceral pain during gastrointestinal disease.

20 part of the investigation and management of gastrointestinal disease.

21 lution and an increased risk of exacerbating gastrointestinal disease.

22 hogen that plays a role in acute and chronic gastrointestinal disease.

23 ng platform for the study of inflammation in gastrointestinal disease.

24 in neonates, in some cases, without causing gastrointestinal disease.

25 with a change in bowel habit and no organic gastrointestinal disease.

26 isease, were classified as having no organic gastrointestinal disease.

27 verity of a plethora of illnesses, including gastrointestinal disease.

28 both inflammatory and malignancy associated gastrointestinal disease.

29 s well as many cases of non-food-borne human gastrointestinal disease.

30 part of the investigation and management of gastrointestinal disease.

31 ic illnesses such as respiratory distress or gastrointestinal disease.

32 knowledge for future investigations of human gastrointestinal diseases.

33 y be useful for preventing cytokine-mediated gastrointestinal diseases.

34 early stages of development for treatment of gastrointestinal diseases.

35 ticle will review the role of polyphenols in gastrointestinal diseases.

36 he beneficial effects of polyphenols in many gastrointestinal diseases.

37 for cutaneous manifestations of inflammatory gastrointestinal diseases.

38 including drug delivery in the treatment of gastrointestinal diseases.

39 itis and may have therapeutic application in gastrointestinal diseases.

40 pict its potential role in the management of gastrointestinal diseases.

41 een invoked as mediators of tissue injury in gastrointestinal diseases.

42 investigator to better understand and treat gastrointestinal diseases.

43 acterium shown to be linked with a series of gastrointestinal diseases.

44 improved interventions to prevent and treat gastrointestinal diseases.

45 argeted therapeutic options for a variety of gastrointestinal diseases.

46 cterization and pathophysiology of a host of gastrointestinal diseases.

47 ersial bacteria in the world causing diverse gastrointestinal diseases.

48 e can potentially be used to protect against gastrointestinal diseases.

49 ved asthma control, and lower risk of select gastrointestinal diseases.

50 eases as well as in a number of inflammatory gastrointestinal diseases.

51 flammatory bowel diseases are costly chronic gastrointestinal diseases.

52 show promise for the treatment of pediatric gastrointestinal diseases.

53 y new ablative modality for the treatment of gastrointestinal diseases.

54 in the diagnosis and surveillance of various gastrointestinal diseases.

55 ess (chronic stress) often causes functional gastrointestinal diseases.

56 pment of new therapeutic strategies for many gastrointestinal diseases.

57 for its potential activity in a multitude of gastrointestinal diseases.

58 vs 13 % and 14 %, P < 0.001), had less other gastrointestinal diseases (8 % vs 40 % and 25 %, P = 0.0

59 f anti-transglutaminase 2 IgA is linked with gastrointestinal disease, an anti-transglutaminase 6 IgG

60 re associated with an increased incidence of gastrointestinal disease and AIDS-related mortality.

61 herapeutic intervention in the management of gastrointestinal disease and cancer.

62 We identified associated gastrointestinal disease and developmental regression in

63 Gastrointestinal disease and inflammation are common seq

64 sts that development of a vaccine to prevent gastrointestinal disease and limit colonization is possi

65 n 30 days who were diagnosed with a surgical gastrointestinal disease and PN dependent for at least 2

66 57:H7 are a significant cause of hemorrhagic gastrointestinal disease and the hemolytic uremic syndro

67 ichia coli O157:H7, has been associated with gastrointestinal disease and the life-threatening sequel

68 A isolates causing both non-food-borne human gastrointestinal disease and veterinary disease carry th

69 nduction of HO-1 may find therapeutic use in gastrointestinal diseases and injuries.

70 al developments in the field of eosinophilic gastrointestinal diseases and the contribution of basic

71 ulence determinant in Yersinia spp., causing gastrointestinal diseases and the plague.

72 t in colostrum, for the treatment of various gastrointestinal diseases and the relative merits of the

73 ts into the pathogenesis of common liver and gastrointestinal diseases and to new treatment strategie

74 f review discusses a variety of food-induced gastrointestinal diseases and will highlight the recent

75 5 fimbriae (from bacteria primarily causing gastrointestinal disease) and class 1 pili (from bacteri

76 articular, limb, or back pain, headaches, or gastrointestinal diseases) and their relationship with m

77 Injury, renal failure, gastrointestinal disease, and cardiovascular conditions

78 eal reflux disease (GERD) is the most common gastrointestinal disease, and the cost of health care an

79 gnificant factor in the pathogenesis in many gastrointestinal diseases, and is perhaps the most clini

80 Abdominal pain predominant functional gastrointestinal diseases (AP-FGD) are commonly seen in

81 Reduced intestinal CD4 T cell numbers and gastrointestinal disease are common features of acquired

82 Viral gastrointestinal diseases are a leading cause of childho

83 radiology techniques useful for treatment of gastrointestinal diseases are also discussed.

84 l therapeutic strategies in the treatment of gastrointestinal diseases associated with altered IESC f

85 s available to inhibit apoptosis for various gastrointestinal diseases associated with cell death and

86 y allow therapeutic relief for patients with gastrointestinal diseases associated with pain.

87 a point-of-care system for fast detection of gastrointestinal diseases at early stages.

88 A higher gastrointestinal disease burden was also seen in childre

89 (PPIs) are widely used for the treatment of gastrointestinal diseases but have also been shown to be

90 This antibiotic may be effective for other gastrointestinal diseases, but more well designed clinic

91 ease (IBD) is one of the most common chronic gastrointestinal diseases, but the underlying molecular

92 mplicated in the pathogenesis of a number of gastrointestinal diseases, but we have limited understan

93 m and Ruvettus pretiosus is related with the gastrointestinal disease called Keriorrhea.

94 ted with malabsorption of macronutrients and gastrointestinal disease can impair copper uptake and co

95 l eggs, since approximately 80% of all human gastrointestinal diseases can be traced to contaminated

96 solates responsible for non-food-borne human gastrointestinal diseases carry a plasmid cpe gene.

97 pilus (TCP) and cholera toxin--to cause the gastrointestinal disease cholera.

98 Progress in the pharmacotherapy of pediatric gastrointestinal diseases continued during 1998 despite

99 Although poor sleep is common in numerous gastrointestinal diseases, data are scarce on the risk o

100 and their FLT results were compared to their gastrointestinal disease diagnoses at time of discharge.

101 Female gender and a pretransplant upper gastrointestinal disease diagnosis predicted posttranspl

102 Patients with eosinophilic gastrointestinal disease (EGID), patients with atopic de

103 Eosinophilic gastrointestinal diseases (EGIDs) are an increasingly co

104 role of the microbiome in most eosinophilic gastrointestinal diseases (EGIDs) is not yet known.

105 ght loss, family history of selected organic gastrointestinal diseases, evidence of gastrointestinal

106 utoinflammatory episodes, including aphthae, gastrointestinal disease, febrile attacks, and small-ves

107 s and waterborne diseases, such as childhood gastrointestinal diseases; food insecurity, including re

108 of 1,051,146 patients/year with diagnosis of gastrointestinal diseases (GI).

109 Gastrointestinal disease has been recognized as a major

110 Their involvement in gastrointestinal diseases has been acknowledged, but rel

111 Associations between virus and other gastrointestinal diseases have been evaluated as well, a

112 Studies of monogenic gastrointestinal diseases have revealed molecular pathwa

113 obstructive pulmonary disease, eosinophilic gastrointestinal diseases, hyper-eosinophilic syndrome,

114 BPV), the causative agent of respiratory and gastrointestinal disease in cows, is the type member of

115 most frequent bacterial causes of food-borne gastrointestinal disease in developed countries.

116 is now the most frequently reported cause of gastrointestinal disease in England and Wales, yet few i

117 r of novel Helicobacter spp. associated with gastrointestinal disease in humans and animals is rapidl

118 ram-negative bacterium, is a common cause of gastrointestinal disease in humans.

119 stridium perfringens causes gas gangrene and gastrointestinal disease in humans.

120 is associated with enhanced protection from gastrointestinal disease in infants, mediated in part by

121 tis (NEC) is the leading cause of death from gastrointestinal disease in newborn infants and is chara

122 and ulcerative colitis are common causes of gastrointestinal disease in northern Europe, affecting a

123 tis (NEC) is the leading cause of death from gastrointestinal disease in preterm infants and is chara

124 leading cause of gastrointestinal death from gastrointestinal disease in preterm infants, is characte

125 rocolitis is the leading cause of death from gastrointestinal disease in preterm infants.

126 tage of robust information about profiles of gastrointestinal disease in sub-Saharan Africa.

127 ace/ethnicity, immune status, or symptoms of gastrointestinal disease in the children studied.

128 This outbreak is another example of gastrointestinal disease in the United States associated

129 litis (NEC), the leading cause of death from gastrointestinal diseases in preterm infants.

130 associated with signs of postwar cardiac and gastrointestinal disease (incidence risk ratio [IRR], 1.

131 Cystic fibrosis gastrointestinal disease includes nutrient malabsorption

132 re now headed for clinical trials in several gastrointestinal diseases including inflammatory bowel d

133 Several gastrointestinal diseases including the inflammatory bow

134 n vitro model among caliciviruses that cause gastrointestinal disease, including members of the gener

135 ated with cancer development in a variety of gastrointestinal diseases, including cholangiocarcinoma.

136 n (cpe) gene are an important cause of human gastrointestinal diseases, including food poisoning, ant

137 cycle arrest that has been involved in many gastrointestinal diseases, including human cholestatic l

138 ier function are associated with a number of gastrointestinal diseases, including neonatal necrotizin

139 Persistent gastrointestinal disease/inflammation has been proposed

140 strointestinal tract and its relationship to gastrointestinal disease, interest has expanded to inclu

141 Eosinophilic gastrointestinal diseases involving the rest of the gast

142 These data suggest that the SIV-associated gastrointestinal disease is associated with the presence

143 udies that attempted to quantify the risk of gastrointestinal disease linked to the consumption of ha

144 discusses CAM use in three types of chronic gastrointestinal diseases-liver disease, irritable bowel

145 The detection of pathogens associated with gastrointestinal disease may be important in certain pat

146 nt recipients with recurrent cytomegalovirus gastrointestinal disease may resolve their symptoms.

147 Loss of ICC in human gastrointestinal diseases may contribute to the motor pa

148 function, at the organ level, in a dysmotile gastrointestinal disease model.

149 Barrett's metaplasia (N = 16), benign upper gastrointestinal diseases (N = 62), or a normal upper ga

150 zing enterocolitis (NEC), a life-threatening gastrointestinal disease of premature infants characteri

151 otizing enterocolitis (NEC) is a devastating gastrointestinal disease of premature infants partly cau

152 and Eimeria, two major infectious agents of gastrointestinal diseases of poultry of economic importa

153 er, and from 9 controls (individuals free of gastrointestinal disease or diabetes).

154 cluded from the study if they had coexisting gastrointestinal disease or had a substantial coexisting

155 educe systemic inflammation in patients with gastrointestinal diseases or metabolic syndrome.

156 of osteoarthritis (OR 2.6, 95% CI 1.7-3.8), gastrointestinal disease (OR 2.3, 95% CI 1.2-4.5), and c

157 ly isolated from patients with endocarditis, gastrointestinal disease, or both.

158 Yet in various inflammatory gastrointestinal diseases, over-secretion of anions resu

159 IDO1 activity significantly shapes gastrointestinal disease pathophysiology and severity.

160 remia and endocarditis with various forms of gastrointestinal disease (primarily colonic cancers).

161 Cattle are the most relevant model of gastrointestinal disease resulting from nontyphoidal Sal

162 to the pathogenesis of non-food-borne human gastrointestinal disease strain F5603.

163 ics, including medications intended to treat gastrointestinal diseases, such as antitumor necrosis fa

164 As more neonates with gastrointestinal diseases survive into adulthood, their

165 appear to influence whether neonates develop gastrointestinal disease symptoms.

166 viruses, influence whether neonates develop gastrointestinal disease symptoms.

167 ncy virus (SIV) infection is associated with gastrointestinal disease, systemic immune activation, an

168 Cryptosporidium spp. cause acute gastrointestinal disease that can be fatal for immunocom

169 ome countries (LMICs) face a large burden of gastrointestinal diseases that benefit from prompt endos

170 ecommended evaluation and treatments for the gastrointestinal diseases that most commonly mimic the p

171 In the context of gastrointestinal disease, the bacterium enterotoxigenic

172 No other hemorrhagic gastrointestinal disease was detected.

173 tory cytokine, in cytomegalovirus-associated gastrointestinal disease, we quantitated the level of TN

174 f oral antigen-induced eosinophil-associated gastrointestinal disease, we report the pathological con

175 Patients <18 years or with unrelated gastrointestinal disease were excluded.

176 APACHE II predictions for patients with gastrointestinal disease were significantly better.

177 Enterocytozoon bieneusi is known to cause a gastrointestinal disease whereas Encephalitozoon intesti

178 gitis is an increasingly recognized allergic gastrointestinal disease, which is becoming more common.

179 diagnostic approach to several food-induced gastrointestinal diseases will be individually examined.

180 unctional or structural lung impairment, and gastrointestinal disease with or without malabsorption,

181 Non-typhoidal Salmonella are associated with gastrointestinal disease worldwide and invasive disease